Inhibition of the schizophrenia-associated microRNA miR-137 disrupts Nrg1α neurodevelopmental signal transduction Open Access
Thomas, Kristen Therese (2017)
Abstract
Defects in neural development play a well-substantiated but poorly understood role in schizophrenia etiology. Genomic studies have repeatedly associated variants in the gene encoding microRNA miR-137 with schizophrenia, but whether miR-137 contributes to the dysregulation of neurodevelopmental signal transduction in schizophrenia is unknown. Bioinformatic predictions suggest that the PI3K-Akt-mTOR branch of neuregulin (Nrg)/ErbB signaling may be particularly enriched with miR-137 targets. In the present study, we demonstrate that miR-137 regulates neuronal levels of p55γ, PTEN, Akt2, GSK3β, mTOR, and rictor. Inhibition of miR-137 ablates Nrg1α-induced increases in dendritic protein synthesis, phospho(Ser235/236)-S6, AMPA receptor subunits, and dendritic outgrowth, demonstrating a profound disruption of Nrg/ErbB signaling. Furthermore, inhibition of miR-137 blocks mTORC1-dependent responses to BDNF, including increased protein synthesis and dendritic outgrowth, while leaving mTORC1-independent S6 phosphorylation intact. Together, our results demonstrate that miR-137 regulates neuronal responses to Nrg1α and BDNF through convergent mechanisms and provide a novel mechanism by which miR-137 may regulate neural development and contribute to schizophrenia.
Table of Contents
Table of Contents
Chapter 1 General Introduction......................................................................................... 1
1.1 miRNAs: history and significance............................................................................ 2
1.2 miRNA biogenesis and mRNA targeting................................................................... 4
1.3 miRNA mechanisms of action.................................................................................. 81.4 miRNAs play diverse roles in the regulation and dysregulation of neuronal signaling 10
1.4.1 miRNAs regulate neuronal signaling.............................................................. 111.4.2 Neuronal signaling regulates the miRNA pathway......................................... 17
1.4.3 miRNAs regulate the neuronal circuitry......................................................... 21
1.5 The schizophrenia-associated miRNA miR-137 regulates neuronal signaling......... 25
1.5.1 miR-137 and 1p21.3 deletion syndrome........................................................ 25
1.5.2 miR-137 and schizophrenia........................................................................... 26
1.5.3 miR-137 in neuronal signaling and synaptic function.................................... 30
1.5.4 miR-137 target predictions and pathway analysis.......................................... 33
1.6 Dissertation Hypothesis and Objectives.................................................................. 34
1.7 Materials and Methods............................................................................................ 35
1.8 Figures.................................................................................................................... 361.9 Tables..................................................................................................................... 38
Chapter 2 miR-137 targets mRNAs encoding proteins within the
PI3K-Akt-mTOR pathway................................................................................................ 402.1 Introduction............................................................................................................ 41
2.1.1 The PI3K-Akt-mTOR pathway: general structure and function..................... 41
2.1.2 The PI3K-Akt-mTOR pathway in neuronal signaling..................................... 44
2.1.3 The PI3K-Akt-mTOR pathway in neurodevelopmental disease..................... 45
2.1.4 miR-137 and the PI3K-Akt-mTOR pathway.................................................. 46
2.1.5 Chapter 2 hypothesis and objectives.............................................................. 47
2.2 Results.................................................................................................................... 47
2.2.1 miR-137 negatively regulates neuronal p55γ levels....................................... 48
2.2.2 miR-137 negatively regulates neuronal PTEN levels...................................... 49
2.2.3 miR-137 negatively regulates neuronal Akt2 levels....................................... 49
2.2.4 miR-137 negatively regulates neuronal GSK3β levels................................... 49
2.2.5 miR-137 negatively regulates neuronal rictor levels....................................... 50
2.2.6 miR-137 negatively regulates neuronal mTOR levels.................................... 50
2.3 Discussion.............................................................................................................. 51
2.4 Materials and Methods............................................................................................ 54
2.5 Figures.................................................................................................................... 60
2.6 Supplemental Figures.............................................................................................. 66
Chapter 3 Inhibition of miR-137 blocks Nrg1 signaling.................................................. 673.1 Introduction............................................................................................................ 68
3.1.1 The Nrg/ErbB pathway: general structure and function................................. 68
3.1.2 The Nrg/ErbB pathway in neural development and function......................... 70
3.1.3 The Nrg/ErbB pathway in psychiatric disease................................................ 72
3.1.4 Chapter 3 hypothesis and objectives.............................................................. 73
3.2 Results.................................................................................................................... 74
3.2.1 Nrg1α increases dendritic phospho-S6 by an ErbB
receptor-dependent mechanism..................................................................... 74
3.2.2 Nrg1α increases dendritic phospho-S6 and mRNA translation
by a miR-137 dependent mechanism............................................................. 75
3.2.3 Nrg1α increases dendritic phospho-S6 and mRNA translation
by an mTORC1-dependent mechanism......................................................... 76
3.2.4 Nrg1α increases dendritic MAP2 by a miR-137-dependent mechanism......... 76
3.2.5 Nrg1α does not affect total or dendritic levels of miR-137............................ 77
3.2.6 Nrg1α increases dendritic outgrowth by an ErbB-dependent mechanism....... 77
3.2.7 Nrg1α increases dendritic outgrowth by a miR-137-dependent mechanism... 78
3.2.8 Nrg1α increases dendritic outgrowth by an mTOR-dependent mechanism.... 78
3.2.9 Nrg1β increases dendritic outgrowth by a miR-137-dependent mechanism... 79
3.3 Discussion.............................................................................................................. 79
3.3.1 The role of Nrg1α.......................................................................................... 79
3.3.2 Significance for schizophrenia...................................................................... 81
3.3.3 Model............................................................................................................ 82
3.3.4 Alternative mechanism.................................................................................. 83
3.4 Materials and Methods............................................................................................ 84
3.5 Figures.................................................................................................................... 89
3.6 Supplemental Figures............................................................................................ 103
Chapter 4 Regulation of AMPA receptor subunits by miR-137 and Nrg1α.................. 107
4.1 Introduction.......................................................................................................... 108
4.1.1 AMPAR subunits: general structure and function........................................ 108
4.1.2 AMPAR subunits in neurodevelopmental disease........................................ 110
4.1.3 Regulation of GluA1 by miR-137................................................................ 112
4.1.4 Regulation of AMPAR subunits by Nrg1/ErbB signaling............................. 112
4.1.5 Chapter 4 hypothesis and objectives............................................................ 113
4.2 Results.................................................................................................................. 113
4.2.1 miR-137 targets the mouse Gria1-3'UTR..................................................... 113
4.2.2 Nrg1α increases total GluA1/2 protein levels in neurons............................. 115
4.2.3 Nrg1α increases GluA1/2 protein by a miR-137-dependent mechanism...... 115
4.3 Discussion............................................................................................................ 116
4.3.1 miR-137 regulates the AMPAR subunits GluA1 and GluA2........................ 117
4.3.2 Nrg1α, miR-137, and GluA1 regulate dendritic outgrowth
and synaptic plasticity: a shared mechanism?.............................................. 118
4.3.3 Implications for neurodevelopmental disorders........................................... 119
4.4 Materials and Methods.......................................................................................... 120
4.5 Figures.................................................................................................................. 125
4.6 Supplemental Figures............................................................................................ 132
Chapter 5 miR-137 regulates mTOR-dependent responses to BDNF........................... 1335.1 Introduction.......................................................................................................... 134
5.1.1 BDNF signaling: general structure and function........................................... 134
5.1.2 BDNF in neurodevelopmental disease......................................................... 135
5.1.3 Chapter 5 hypothesis and objectives............................................................ 137
5.2 Results.................................................................................................................. 137
5.2.1 BDNF stimulates dendritic outgrowth by an mTOR-
and miR-137-dependent mechanism........................................................... 138
5.2.2 BDNF stimulates S6 phosphorylation by an mTOR-
and miR-137-independent mechanism........................................................ 139
5.2.3 BDNF stimulates mRNA translation in dendrites by
a miR-137-dependent mechanism............................................................... 139
5.3 Discussion............................................................................................................ 140
5.3.1 Future directions.......................................................................................... 142
5.3.2 Significance for neurodevelopmental disorders........................................... 143
5.4 Materials and Methods.......................................................................................... 144
5.5 Figures.................................................................................................................. 146
5.6 Supplemental Figures............................................................................................ 151
Chapter 6 General Discussion........................................................................................ 1526.1 Summary.............................................................................................................. 153
6.2 A novel role for miR-137 in neuronal signaling and neurodevelopment............... 153
6.3 Significance for schizophrenia and other neurodevelopmental disorders............. 154
6.3.1 miR-137 and 1p21.3 deletion syndrome...................................................... 154
6.3.2 miR-137 and schizophrenia......................................................................... 155
6.3.3 miR-137 and Fragile X Syndrome............................................................... 156
6.4 Future Directions.................................................................................................. 158
6.4.1 Examine the regulation of neuronal signaling by miR-137 in disease models 158
6.4.2 Explore the relationship between miR-137 and FMRP................................. 160
6.4.3 Identify the mechanism by which miR-137 disrupts
PI3K-Akt-mTOR signaling........................................................................... 162
6.5 Concluding Remarks............................................................................................ 164
6.6 Figures.................................................................................................................. 166
References....................................................................................................................... 167
Chapter 1 General Introduction
Figure 1.1 miR-137 targets within the Nrg/ErbB, BDNF, and LTP pathways................ 36
Figure 1.2 Proposed relationship between miR-137 targets within the
PI3K-Akt-mTOR branch of Nrg/ErbB signaling........................................... 37
Table 1.1 miR-137 targets are enriched in pathways relevant to neuronal signaling...... 38
Table 1.2 Predicted miR-137 targets within the PI3K-Akt-mTOR branch
of Nrg/ErbB signaling.................................................................................... 39
Chapter 2 miR-137 targets mRNAs encoding proteins within the PI3K-Akt-mTOR pathway
Figure 2.1 miR-137 targets the PIK3R3-3'UTR and regulates neuronal p55γ protein.... 60
Figure 2.2 miR-137 targets the PTEN-3'UTR and regulates neuronal PTEN protein..... 61
Figure 2.3 miR-137 regulates neuronal Akt2 protein.................................................... 62
Figure 2.4 miR-137 targets the GSK3B-3'UTR and regulates neuronal GSK3β
protein levels without affecting phosphorylation at Ser9............................... 63
Figure 2.5 miR-137 targets the RICTOR-3'UTR and regulates neuronal rictor protein.. 64
Figure 2.6 miR-137 regulates neuronal mTOR levels but not phosphorylation at Ser2448........... 65
Supplemental Figure 2.1 Validation of pre-miR-137 overexpression plasmid used
in neuronal experiments................................................................................ 66
Chapter 3 Inhibition of miR-137 blocks Nrg1 signaling
Figure 3.1 Timeline for experiments using acute Nrg1α stimulation.............................. 89
Figure 3.2 Nrg1α increases dendritic phospho(Ser235/236)-S6 by an ErbB
receptor-dependent mechanism..................................................................... 90
Figure 3.3 Inhibition of miR-137 blocks Nrg1α-induced increases in dendritic
phospho(Ser235/236)-S6 and mRNA translation........................................... 91
Figure 3.4 Inhibition of mTORC1 blocks Nrg1α-induced increases in dendritic
phospho(Ser235/236)-S6 and mRNA translation........................................... 93
Figure 3.5 Nrg1α increases dendritic MAP2 by a miR-137-dependent mechanism....... 95
Figure 3.6 Experimental timeline and Sholl methodology for Nrg1α morphology
experiments................................................................................................... 96Figure 3.7 Nrg1α increases dendritic outgrowth in DIV4 primary cortical neurons
by an ErbB receptor-dependent mechanism.................................................. 97
Figure 3.8 Nrg1α increases dendritic outgrowth by a miR-137-dependent mechanism. 98
Figure 3.9 Inhibition of mTOR blocks Nrg1α-induced dendritic outgrowth................ 100
Figure 3.10 Inhibition of miR-137 blocks Nrg1β-induced dendritic outgrowth........... 101
Figure 3.11 Model for miR-137 regulating Nrg1α signal transduction......................... 102
Supplemental Figure 3.1 Inhibition of miR-137 increases dendritic GSK3β without
blocking Nrg1α-induced dephosphorylation at Ser9.................................... 103
Supplemental Figure 3.2 Model for Nrg1α regulating miR-137 levels or activity........ 104
Supplemental Figure 3.3 Acute Nrg1α treatment does not affect total or dendritic
levels of miR-137........................................................................................ 105
Supplemental Figure 3.4 Two-day Nrg1α treatment does not affect miR-137 levels... 106
Chapter 4 Regulation of AMPA receptor subunits by miR-137 and Nrg1α
Figure 4.1 miR-137 inhibits Gria1-3'UTR luciferase reporter activity........................ 125
Figure 4.2 miR-137 associates with Gria1 mRNA in vitro in a site and
sequence-specific manner........................................................................... 126
Figure 4.3 miR-137 inhibits GluA1 and GluA2 protein levels in cortical neurons...... 127
Figure 4.4 Nrg1α increases GluA1 and GluA2 protein levels without affecting
mRNA levels............................................................................................... 128
Figure 4.5 Inhibition of miR-137 blocks Nrg1α-induced increases in dendritic
GluA1 and GluA2....................................................................................... 129
Figure 4.6 Inhibition of miR-137 blocks Nrg1α induced GluA1 synthesis.................. 130
Figure 4.7 Model for miR-137 regulating Nrg1α-induced changes in GluA1 levels.... 131
Supplemental Figure 4.1 Nrg1α does not affect miR-137's ability to assemble
on Gria1 mRNA in vitro.............................................................................. 132
Chapter 5 miR-137 regulates mTOR-dependent responses to BDNF
Figure 5.1 BDNF stimulates dendritic outgrowth by an mTOR- and miR-137-
dependent mechanism................................................................................. 146
Figure 5.2 BDNF stimulates S6 phosphorylation by an mTOR- and miR-137-
independent mechanism.............................................................................. 148
Figure 5.3 BDNF stimulates mRNA translation in dendrites by a miR-137-
dependent mechanism................................................................................. 150
Supplemental Figure 5.1 30 min treatment with BDNF does not affect miR-137
levels in cortical neurons............................................................................. 151
Chapter 6 General Discussion
Figure 6.1 Proposed roles for miR-137 at the glutamatergic synapse 166
About this Dissertation
- Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School | |
---|---|
Department | |
Subfield / Discipline | |
Degree | |
Submission | |
Language |
|
Research Field | |
Keyword | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
|
Inhibition of the schizophrenia-associated microRNA miR-137 disrupts Nrg1α neurodevelopmental signal transduction () | 2018-08-28 16:23:36 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|